CN100427094C - Usage of alpha-(Morpholin-1-base) methyl-2-methyl-5-azathio-1-alcohol in preparation of anti-trichomoniasis and anti-ameba medicines - Google Patents
Usage of alpha-(Morpholin-1-base) methyl-2-methyl-5-azathio-1-alcohol in preparation of anti-trichomoniasis and anti-ameba medicines Download PDFInfo
- Publication number
- CN100427094C CN100427094C CNB2005101342543A CN200510134254A CN100427094C CN 100427094 C CN100427094 C CN 100427094C CN B2005101342543 A CNB2005101342543 A CN B2005101342543A CN 200510134254 A CN200510134254 A CN 200510134254A CN 100427094 C CN100427094 C CN 100427094C
- Authority
- CN
- China
- Prior art keywords
- methyl
- preparation
- ameba
- ethanol
- alpha
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Abstract
Description
Chemical compound | Oral 2000mg/kg mortality rate (%) | Lumbar injection 2000mg/kg mortality rate (%) |
The embodiment chemical compound | 0 | 0 |
Metronidazole | 30 | 40 |
Ornidazole | 50 | 70 |
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005101342543A CN100427094C (en) | 2005-12-13 | 2005-12-13 | Usage of alpha-(Morpholin-1-base) methyl-2-methyl-5-azathio-1-alcohol in preparation of anti-trichomoniasis and anti-ameba medicines |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005101342543A CN100427094C (en) | 2005-12-13 | 2005-12-13 | Usage of alpha-(Morpholin-1-base) methyl-2-methyl-5-azathio-1-alcohol in preparation of anti-trichomoniasis and anti-ameba medicines |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1981764A CN1981764A (en) | 2007-06-20 |
CN100427094C true CN100427094C (en) | 2008-10-22 |
Family
ID=38164796
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2005101342543A Active CN100427094C (en) | 2005-12-13 | 2005-12-13 | Usage of alpha-(Morpholin-1-base) methyl-2-methyl-5-azathio-1-alcohol in preparation of anti-trichomoniasis and anti-ameba medicines |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100427094C (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104628651B (en) * | 2013-11-06 | 2018-07-24 | 江苏豪森药业集团有限公司 | Morpholine nitre azoles isomers and preparation method thereof |
CN104844522B (en) * | 2015-05-05 | 2017-07-25 | 江苏豪森药业集团有限公司 | Morpholine nitre azoles crystal and preparation method thereof and medical usage |
CN104829541B (en) * | 2015-05-05 | 2017-06-30 | 江苏豪森药业集团有限公司 | The method that high selectivity and high-purity prepare morpholine nitre azoles |
CN107556304B (en) * | 2016-06-30 | 2022-06-03 | 华创合成制药股份有限公司 | Nitroimidazole medicine and preparation method and application thereof |
CN114907250A (en) * | 2021-02-06 | 2022-08-16 | 华创合成制药股份有限公司 | Deuterated morpholine ornidazole and application thereof |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1390836A (en) * | 2002-07-19 | 2003-01-15 | 中国科学院上海有机化学研究所 | Optical antimer of Saikexiaozuo and its preparing process and usage |
CN1605586A (en) * | 2003-10-08 | 2005-04-13 | 连云港恒邦医药科技有限公司 | Alpha-substituted 2-methyl-5-nitroimidazole-1-ethanol derivatives |
-
2005
- 2005-12-13 CN CNB2005101342543A patent/CN100427094C/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1390836A (en) * | 2002-07-19 | 2003-01-15 | 中国科学院上海有机化学研究所 | Optical antimer of Saikexiaozuo and its preparing process and usage |
CN1605586A (en) * | 2003-10-08 | 2005-04-13 | 连云港恒邦医药科技有限公司 | Alpha-substituted 2-methyl-5-nitroimidazole-1-ethanol derivatives |
Also Published As
Publication number | Publication date |
---|---|
CN1981764A (en) | 2007-06-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2001509157A (en) | Time-specific controlled-release dosage formulation and its preparation | |
CN100427094C (en) | Usage of alpha-(Morpholin-1-base) methyl-2-methyl-5-azathio-1-alcohol in preparation of anti-trichomoniasis and anti-ameba medicines | |
WO2010040286A1 (en) | Triacetyl-3-hydroxyphenyladenosine and its use for regulating blood fat | |
CN101674823A (en) | Method for the treatment of conditions associated with increased 5-lipoxygenase and/or leukotriene activity | |
CN1315177A (en) | Method for curing sexual dysfunction by specific blood plasma concentration apomorphine | |
US20070112065A1 (en) | Use of l-butylphthalide in the manufacture of medicaments for prevention and treatment of cerebral infarct | |
CN107987033A (en) | The application of vanillic aldehyde and its isomers in NA inhibitor is prepared | |
CN100418526C (en) | Use of irbesartan for the preparation of medicaments that are used to prevent or treat pulmonary hypertension | |
CN101357134A (en) | Potenciador del efecto antitumoral y agente antitumoral | |
CN100450528C (en) | Funing gel prepn. and its prepn. method | |
WO2006058457A1 (en) | α-SUBSTITUTED 2-METHYL-5-NITROIMIDAZOL-1-ETHANOL DERIVATIVES | |
CN1995036B (en) | Optical purity alpha-substituted 2-methyl-5-nitro imidazole-1-ethanol derivative | |
CN110229081B (en) | 2, 4-dinitrophenylhydrazone derivative and preparation method and application thereof | |
CN115925640A (en) | ((3-carbamoyl-5-fluoropyrazin-2-yl) oxy) methyl isobutyrate and preparation method and application thereof | |
KR100192534B1 (en) | Agent for increasing somatostatin or for inhibiting decrease of somatostatin | |
CN104582704A (en) | Composition for treating or preventing diseases caused by vascular permeability, containing imatinib or pharmaceutically acceptable salt thereof as active ingredient | |
WO2013060275A1 (en) | Application of albizzia chinensis extract in preparation of medicine for treatment of gastric ulcer | |
CN109305979B (en) | Application of 4-dimethylaminobenzaldehyde in preparation of NA inhibitor | |
CN101190890B (en) | 5-[(2R)-[2-[2-[2-(2,2,2-trifluoroethoxyl)phenoxyl]ethyl]amino]propyl]-2-methoxylbenzsulfamide | |
CN101822833B (en) | Medicament compound containing theophylines and statins | |
EA003584B1 (en) | A method for promoting smoking cessation or reduction or preventing relapse smoking and use of paroxetine or a pharmaceutically acceptable salt or solvate to produce a medicament | |
CN107286147B (en) | N- [5- (1,2, 4-triazol-1-yl) thiazol-2-yl ] morpholinylamide and medical application thereof | |
CN101658521A (en) | Paracetamol, pseudoephedrine and chlorphenamine compound sustained release preparation | |
CN101397315B (en) | Tonka bean camphor glycosides compounds, preparation method thereof and medicament composition and use thereof | |
CN1791398B (en) | Treating or preventing hot flashes using prodrugs of GABA analogs |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: LIANYUNGANG HONGCHUANG MEDICINE CO., LTD. |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20100520 Address after: 222047 tenth Industrial Zone, Lianyungang economic and Technological Development Zone, Jiangsu, Lianyungang Co-patentee after: Lianyungang Hong Chuang Pharmaceutical Co.,Ltd. Patentee after: JIANGSU HANSOH PHARMACEUTICAL Co.,Ltd. Address before: 222047 tenth Industrial Zone, Lianyungang economic and Technological Development Zone, Jiangsu, Lianyungang Patentee before: JIANGSU HANSOH PHARMACEUTICAL Co.,Ltd. |
|
C56 | Change in the name or address of the patentee | ||
CP01 | Change in the name or title of a patent holder |
Address after: 222047 tenth Industrial Zone, Lianyungang economic and Technological Development Zone, Jiangsu, Lianyungang Co-patentee after: JIANGSU HANSOH PHARMACEUTICAL GROUP LIANYUNGANG HONGCHUANG PHARMACEUTICAL Co.,Ltd. Patentee after: JIANGSU HANSOH PHARMACEUTICAL Co.,Ltd. Address before: 222047 tenth Industrial Zone, Lianyungang economic and Technological Development Zone, Jiangsu, Lianyungang Co-patentee before: Lianyungang Hong Chuang Pharmaceutical Co.,Ltd. Patentee before: JIANGSU HANSOH PHARMACEUTICAL Co.,Ltd. |
|
C56 | Change in the name or address of the patentee | ||
CP03 | Change of name, title or address |
Address after: 222047 tenth Industrial Zone, Lianyungang economic and Technological Development Zone, Jiangsu, Lianyungang Patentee after: JIANGSU HANSOH PHARMACEUTICAL Co.,Ltd. Patentee after: Lianyungang Hongchuang Pharmaceutical Co.,Ltd. Address before: 222047 tenth Industrial Zone, Lianyungang economic and Technological Development Zone, Jiangsu, Lianyungang Patentee before: JIANGSU HANSOH PHARMACEUTICAL Co.,Ltd. Patentee before: JIANGSU HANSOH PHARMACEUTICAL GROUP LIANYUNGANG HONGCHUANG PHARMACEUTICAL Co.,Ltd. |
|
C41 | Transfer of patent application or patent right or utility model | ||
C56 | Change in the name or address of the patentee | ||
CP01 | Change in the name or title of a patent holder |
Address after: 222047 tenth Industrial Zone, Lianyungang economic and Technological Development Zone, Jiangsu, Lianyungang Patentee after: JIANGSU HANSOH PHARMACEUTICAL GROUP Co.,Ltd. Patentee after: Lianyungang Hongchuang Pharmaceutical Co.,Ltd. Address before: 222047 tenth Industrial Zone, Lianyungang economic and Technological Development Zone, Jiangsu, Lianyungang Patentee before: Jiangsu best Pharmaceutical Co.,Ltd. Patentee before: Lianyungang Hongchuang Pharmaceutical Co.,Ltd. Address after: 222047 tenth Industrial Zone, Lianyungang economic and Technological Development Zone, Jiangsu, Lianyungang Patentee after: Jiangsu best Pharmaceutical Co.,Ltd. Patentee after: Lianyungang Hongchuang Pharmaceutical Co.,Ltd. Address before: 222047 tenth Industrial Zone, Lianyungang economic and Technological Development Zone, Jiangsu, Lianyungang Patentee before: JIANGSU HANSOH PHARMACEUTICAL Co.,Ltd. Patentee before: Lianyungang Hongchuang Pharmaceutical Co.,Ltd. |
|
TR01 | Transfer of patent right |
Effective date of registration: 20160324 Address after: 222047 Lianyungang economic and Technological Development Zone, Jiangsu Patentee after: JIANGSU HANSOH PHARMACEUTICAL GROUP Co.,Ltd. Address before: 222047 tenth Industrial Zone, Lianyungang economic and Technological Development Zone, Jiangsu, Lianyungang Patentee before: JIANGSU HANSOH PHARMACEUTICAL GROUP Co.,Ltd. Patentee before: Lianyungang Hongchuang Pharmaceutical Co.,Ltd. |